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The prevalence of obesity in children and adults in the United States has increased dramatically over the past decade. Genomic copy
number variations (CNVs) have been strongly implicated in subjects with extreme obesity and coexisting developmental delay.
To complement these previous studies, we addressed CNVs in common childhood obesity by examining children with a BMI in the
upper 5th percentile but excluding any subject greater than three standard deviations from the mean in order to reduce severe cases
in the cohort. We performed a whole-genome CNV survey of our cohort of 1080 defined European American (EA) childhood obesity
cases and 2500 lean controls (< 50th percentile BMI) who were genotyped with 550,000 SNP markers. Positive findings were evaluated
in an independent African American (AA) cohort of 1479 childhood obesity cases and 1575 lean controls.We identified 17 CNV loci that
were unique to at least three EA cases and were both previously unreported in the public domain and validated via quantitative PCR.
Eight of these loci (47.1%) also replicated exclusively in AA cases (six deletions and two duplications). Replicated deletion loci consisted
of EDIL3, S1PR5, FOXP2, TBCA, ABCB5, and ZPLD1, whereas replicated duplication loci consisted of KIF2B and ARL15. We also observed
evidence for a deletion at the EPHA6-UNQ6114 locus when the AA cohort was investigated as a discovery set. Although these variants
may be individually rare, our results indicate that CNVs contribute to the genetic susceptibility of common childhood obesity in subjects
of both European and African ancestry.Obesity (MIM 601665) is a major health problem in mod-
ern societies, with increasing prevalence in Western socie-
ties, particularly in children.1 Obesity and its associated
phenotype, insulin resistance, is also considered a contrib-
utor to the major causes of death in the United States and
is an important risk factor for type 2 diabetes (T2D [MIM
125853]), cardiovascular diseases (CVD), hypertension
(MIM 145500), and other chronic diseases. Approximately
70% of obese adolescents grow up to become obese adults;2
indeed, obesity present in adolescence has been shown to
be associated with increased overall mortality in adults.3
Despite environmental changes over the last 30 years, in
particular the unlimited supply of convenient, highly
calorific foods together with a sedentary lifestyle, there is
also strong evidence for a genetic component to the risk
of obesity.4,5 This is reflected in prevalence differences
between racial groups. In addition, the familial occur-
rences of obesity have been long noted with the concor-
dance for fat mass among monozygotic twins, reported
to be 70%–90%, higher than the 35%–45% concordance
in dizygotic twins; as such, the estimated heritability of
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The AmericanIn the past three years, 13 genetic loci have been impli-
cated in BMI from the outcomes of genome-wide associa-
tion studies (GWAS), primarily in adults. Insulin-induced
gene 2 (INSIG2 [MIM 608660]) was the first locus to be
reported by this method as having a role in obesity,9 but
replication attempts have yielded inconsistent outcomes.
The second reported locus, the fat mass- and obesity-
associated gene (FTO [MIM 610966]),10 has been more
robustly observed in other cohorts, including our
own.11–14 Subsequent larger studies have uncovered 11
additional loci;15–17 in addition, copy number variation
(CNV) studies of extreme obesity in children, half of which
had developmental delay, reported rare variants contrib-
uting to the trait.18,19
In the current study we examined CNVs in a large pedi-
atric cohort presenting with common obesity that is
primarily nonsyndromic. For this purpose, we performed
a whole-genome CNV study in a large cohort of child-
hood-obesity cases and lean controls of European ancestry
who were genotyped with the Illumina Infinium II
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provided high confidence for CNV calls. Importantly, the
simultaneous analysis of intensity data and genotype data
in the same experimental setting established a highly accu-
rate definition for normal diploid states and any deviation
thereof. To call CNVs, we used the PennCNV algorithm,20
which combines multiple sources of information, in-
cluding log R ratio (LRR) and B allele frequency (BAF) at
each SNPmarker, along with SNP spacing, a trained hidden
Markov model, and population frequency of the B allele to
generate CNV calls. Each sample had CNV calls blinded
with respect to case status. Positive findings were evaluated
in an independent replication cohort of similar size and of
African ancestry. A flow diagram of the CNV filtering and
testing steps is provided in Figure S1 (available online).
We calculated quality-control measures in our Human-
Hap550 GWAS data on the basis of statistical distributions
to exclude poor-quality DNA samples and false-positive
CNVs. The first threshold is the percentage of attempted
SNPs that were successfully genotyped. Only samples with
call rates > 98% and a standard deviation (SD) of LRR <
0.30 were included. Wave artifacts roughly correlating
with GC content resulting from hybridization bias of low
full-length DNA quantity are known to interfere with
accurate inference of CNVs,21 so only samples in which
the GC wave factor of the LRR ranged between 0.1 <
X < 0.1 were accepted. If the count of CNV calls made
by PennCNV exceeded 100 (Figure S2), the DNA quality
was considered poor; thus, only samples with a CNV call
count < 100 were included. Any duplicate samples (such
as monozygotic twins) had one sample excluded.
Our study consisted of 1080 European American (EA)
obese children (BMI R 95th percentile), 2500 EA lean
controls (BMI < 50th percentile), 1479 African American
(AA) obese children, and 1575 AA lean controls who met
strictly established data-quality thresholds for CNVs. All
subjects were consecutively recruited from theGreater Phil-
adelphia area from 2006 to 2009 at the Children’s Hospital
of Philadelphia, were biologically unrelated on the basis of
available SNP data (pairwise identity by descent [IBD] was
used to filter out individuals showing relatedness above
0.25), and were between 2 and 18 years old (Table S1
outlines the age and gender distribution in the obese and
lean groups in the ethnicities separately). This study was
approvedby the institutional reviewboardof theChildren’s
Hospital of Philadelphia. Parental informed consent was
given for each study participant for both the blood collec-
tion and the subsequent genotyping. Global ancestry was
determined with the use of Eigenstrat to ensure a singular
cluster of ethnic ancestry in the European and African pop-
ulations. BMIR 95th percentile was defined with the use of
the Center for Disease Control (CDC) Z-score ¼ 1.645.
However, all subjects had to be between 3 and þ3 SD of
the CDC-corrected BMI in order to exclude outliers that
could potentially be a result of measurement error or to
eliminate the majority of presumed syndromic cases in
the cohort; this cutoff therefore provided us with a cohort
consisting primarily of common obesity, in contrast to662 The American Journal of Human Genetics 87, 661–666, Novembthe severe obesity cases previously reported,18,19 which
included only cases with > 3 SD. We carefully reviewed
the phenotypes of our controls to remove anyone with a
syndrome,multisystemic disorder, or developmental delay.
An average of 22.0 and19.5CNVcalls per individualwere
made with the PennCNV software in the EA cases and
controls, respectively, 93% of subjects having 8–45 CNV
calls (Figure S2). We called four different copy number
states for the EA case and control cohorts, including 919
and 2109 homozygous deletions (copy number [CN] ¼ 0),
13,678 and 28,917 hemizygous deletions (CN ¼ 1), 6767
and 16,689 one-copy duplications (CN ¼ 3), and 344 and
1139 two-copy duplications (CN ¼ 4), respectively.
Figure S3 shows an example of raw Illumina data as viewed
in the BeadStudio software and the resulting CNV call.
The CNV calls spanned from 3 to 7903 SNPs, with an
average of 19 SNPs per CNV call, and their sizes ranged
from 50 bp to 33 Mb, with an average size of 81 kb.
Ninety-three percent of AA subjects also harbored 8–45
CNV calls (Figure S2). An average of 24.1 and 25.1 CNV
calls per individual were made in AA cases and controls,
respectively. Among them, we identified 897 and 1026
(CN ¼ 0), 25,650 and 28,793 (CN ¼ 1), 8778 and 10,251
(CN ¼ 3), and 418 and 535 (CN ¼ 4) CNV calls, respec-
tively. The CNV calls spanned from 3 to 7903 SNPs, with
an average of 15 SNPs per CNV call, and their sizes ranged
from 50 bp to 33 Mb, with an average size of 67 kb.
To identify genomic loci potentially contributing to
common childhood obesity in the EA subjects, we applied
a segment-based scoring approach that scans the genome
for consecutive SNPs with more frequent copy number
changes in cases compared to controls. The genomic
span for these consecutive SNPs delineates common
CNV regions (CNVRs).
We assessed local ancestry by using the 1 MB region
surrounding each CNV locus, which included an average
of 300 SNP genotypes, resulting in well-clustered popula-
tions without significantly deviating individuals. We
report statistical local minimums to narrow the association
in reference to a region of nominal significance, including
SNPs residing within 1 Mb of each other. Resulting signif-
icant CNVRs were excluded if they met any of the
following criteria: (1) residing on telomere or centromere
proximal cytobands; (2) arising in a ‘‘peninsula’’ of com-
mon CNV arising from variation in boundary truncation
of CNV calling; (3) located in genomic regions with
extremes in GC content that produce hybridization bias;
or (4) made up of samples contributing tomultiple CNVRs.
We identified 34 putative CNVR loci (15 deletions and
19 duplications) that were exclusively present in at least
three EA cases (Fisher’s exact test p% 0.05); however, three
of the deletions proved to be false positives during the vali-
dation process with quantitative PCR (qPCR), a method
commonly used for independent validation of CNVs
(Table S2 and Figure S4). All of our experimental valida-
tions were conducted in a blinded manner by an indepen-
dent investigator group so as to minimize any bias, whicher 12, 2010
adds another level of confidence to the experimental
validation results. Issues related to CNV recurrence, accu-
racy, locus dependence, and difficulties related to GC
content were alleviated by running qPCR in quadruplicate,
observing low SD across runs, assaying control samples for
the same genomic region, and assaying the same samples
in different genomic regions. This validation process
involved probes being selected with the ProbeFinder
v2.41 software (Roche, Indianapolis, IN, USA), and qPCR
was then performed on an Applied Biosystems 7500 Real
Time PCR Instrument or on an Applied Biosystems Prism
7900HT Sequence Detection System. Each sample was
analyzed in quadruplicate, either in 25 ml reaction mixture
(250 nM probe, 900 nM each primer, Fast Start TaqMan
Probe Master from Roche, and 10 ng genomic DNA) or in
10 ml reaction mixture (100 nM probe, 200 nM each
primer, 13 Platinum Quantitative PCR SuperMix-Uracil-
DNA-Glycosylase [UDG] with ROX from Invitrogen, and
25 ng genomic DNA). The values were evaluated with
Sequence Detection Software v2.2.1 supplied by themanu-
facturer. Data analysis was further performed via the DDCT
method. Reference genes, chosen from COBL (MIM
610317), GUSB (MIM 611499), and SNCA (MIM 163890),
were included on the basis of the minimal coefficient of
variation, and data were then normalized by setting
a normal control to a value of 1. None of these rare
CNVs could be effectively tagged by a single common
SNP present on the array (Table S3).
Only 17 of these CNVR loci were unique to our cohort,
i.e., not reported in controls by the Database of Genomic
Variants, of which eight (47.1%) also replicated exclusively
in AA cases (six deletions and two duplications) (Table 1).
The use of a different racial group for replication purposes
represents a higher bar than making similar attempts in
the sameethnicity. For example,when the commonvariant
in TCF7L2 (MIM 602228) associated with type 2 diabetes
was also associated with the disease in Africans with
a similar magnitude,22 it was considered muchmore estab-
lished as having a role in the disease; in addition, our recent
asthma GWAS finding was also observed in African Ameri-
cans, which gave us a much higher level of certainty of
our observation.23 Since many variants have been shown
to have different frequencies in different ethnic groups,
observation of the same CNV as exclusive in EA and AA
cohorts separately for the same phenotype minimizes the
potential for confounding effects of population stratifica-
tion. Figure 1 and Figure 2 visualize representative loci
most frequently harboring deletions or duplications, with
the use of the UCSC Genome Browser, build hg18 (March
2006) of the human genome. We also evaluated whether
any of the key CNVs cosegregated with obesity in families,
where data was available, and wewere able to establish that
at least four of the CNVs were inherited from an obese
parent and at least four were de novo (Table S4).
In order to further establish the significance of these
findings, we looked at the converse situation, i.e., exclusive
CNVRs among the controls. First, whereas exclusivity toThe Americanthree obese subjects constituted a nominally significant
observation among EA cases, ten EA controls were required
to reach the same significance threshold because of the
abundance of controls in our study. Analyzed in this way,
we observed no exclusive deletions and only four exclusive
duplications in the EA controls; however, none of these
duplications replicated exclusively in the AA controls.
As such, in contrast to these control observations, we see
a highly significant overabundance of exclusive CNVRs
in our EA cases that go on to replicate exclusively in our
AA cases, revealing that we have a < 12% false-positive
discovery rate.
We also evaluated large rare deletions present in < 1% of
individuals and> 500 kb in size, as set previously,18 and we
did not observe an excess of large rare deletions genome-
wide (Table S5). This is not unexpected, given that the
previous report found significance only when including
developmental delay subjects and not when severe early-
onset obesity was evaluated alone.
The loci harboring exclusive deletions in cases of both
ethnicities consisted of four genes directly overlapping,
namely S1PR5 (endothelial differentiation, sphingolipid
[MIM 605146]), FOXP2 (forkhead box P2 [MIM 605317]),
TBCA (tubulin-specific chaperone a [MIM 610058]) and
ABCB5 (ATP-binding cassette, sub-family B, member 5
[MIM 611785]), whereas two deletions were closest to
EDIL3 (EGF-like repeats- and discoidin I-like domains-
containing protein 3 [MIM 606018]) and ZPLD1 (zona pel-
lucida-like domain containing 1). Pairwise IBD, both
global and local, yielded low values close to zero among
the five cases with the EDIL3 deletion; although exact
CNV breakpoint sharing between cases was not a necessary
parameter of our analysis, it does suggest that a specific
copy number polymorphism is observed. The two loci
harboring exclusive duplications in cases from both
ethnicities consisted of one gene directly overlapping,
namely ARL15 (ADP-ribosylation factor-like 15), and one
closest to KIF2B (kinesin family member 2B).
The majority of genes residing at the loci uncovered in
this study have not been previously implicated in obesity.
However, the most notable finding is with ARL15, which
was recently uncovered in a GWAS of adiponectin levels,
with the same risk allele also being associated with a higher
risk of coronary heart disease and type 2 diabetes.24
In addition, although members of the human Forkhead
box (FOX) gene family have been strongly implicated
inmetabolic traits,25,26mutations in FOXP2 are best known
for causing developmental speech and language disorders
in humans.27 We thoroughly evaluated the questionnaires
and medical records of the children harboring the FOXP2
deletion and found that five do not have any speech prob-
lems; however, one child with the deletion has isolated
speech delay, with no evidence of any underlying
syndromes or intellectual impairment, and is receiving
speech therapy at age 11. Indeed, poor speech, develop-
mental delay, and obesity are commonly observed con-
comitantly in children with Prader-Willi syndrome.28,29Journal of Human Genetics 87, 661–666, November 12, 2010 663
Table 1. CNVs at the SNP Level Exclusive to Childhood Obesity in the European American Cohort, which Were Both Not Present in the
Public Domain and qPCR Validated, Together with the Replication Attempt Data in African Americans
EA AA
CNV
No. of Cases
Harboring
Exclusively
SNP
Tested
No. of
Cases
Harboring
No. of Controls
Harboring
Distance from
Nearest Gene (bp) Nearest Gene
Deletions
chr5:83835179–83874339 5 rs10051401 1 0 118812 EDIL3
chr19:10489548–10512171 3 rs11670254 5 0 0 S1PR5
chr7:113843696–113859679 3 rs12705964 3 0 0 FOXP2
chr5:77039051–77076628 3 rs384109 2 0 0 TBCA
chr7:20708193–20711088 3 rs12700232 1 0 0 ABCB5
chr3:104059109–104092618 3 rs1144781 1 0 377734 ZPLD1
chr12:16141980–16149714 3 rs1376332 0 0 60398 DERA
chr10:118354808–118363319 3 rs7905887 0 1 0 PNLIPRP1
chr20:5111828–5137472 3 rs17785402 0 0 0 BC015432-CDS2
chr4:35782722–35828015 3 rs4833119 1 1 0 CENTD1
Duplications
chr17:49444406–49449022 3 rs17730346 2 0 186834 KIF2B
chr5:53467427–53480255 3 rs16882296 1 0 0 ARL15
chr12:21446005–21459060 3 rs7953750 0 0 6367 SLCO1A2
chr6:67391945–67395314 3 rs183895 0 2 918106 EGFL11
chr5:90155080–90157263 3 rs7717221 0 0 0 GPR98
chr13:61409439–61413267 3 rs2183953 0 0 509359 PCDH20
chr2:21337060–21342588 3 rs870638 0 0 216610 APOB
EA, European Americans; AA, African Americans; CNV, copy number variant. Those CNVs that replicated exclusively in AA cases are indicated with bold and italics.
Coordinates are derived from UCSC Genome Browser build hg18. The ‘‘Distance from Nearest Gene’’ column lists 0 if the CNV encompasses the gene listed or
a value if the CNV is nearby the gene listed. These loci showed a copy number (CN) ¼ 1 for deletion loci and a CN ¼ 3 for duplication loci across contributing
samples. No other states, such as CN ¼ 0 or CN¼ 4, were observed at these loci. The individual CNV calls are assigned as a SNP-based statistic. Therefore, contig-
uous SNPs showing case nonzero values and control zero values form a region of copy number variation (CNVR), which are the CNVRs listed. The SNP tested is the
central SNP in the CNVR so as to ensure exact overlap in replication.We elected to use the EA cohort for discovery because of
the much larger control group available in this ethnicity to
observe and establish exclusivity most comprehensively in
the discovery setting. However, in order to explore the
possibility of additional exclusive loci, we also went the
other way; i.e., we analyzed the AA cohort as the discovery
cohort and attempted to replicate in the EA cohort (Table
S6). Although exclusivity to five AA cases was required to
achieve nominal significance in the discovery stage in
this setting because of the fewer lean controls in this
cohort (Table S7), we did observe evidence for a deletion
at the EPHA6-UNQ6114 locus (MIM 600066) that was
exclusive to AA cases.
To date, there has been a notable paucity of GWA studies
in childhood obesity, with studies primarily uncovering
loci in the adult setting,10,12,14–17 and no study to date
has reported CNVs that are significantly associated with
the common obesity trait as opposed to the severe
form.18,19 As such, our study represents a large-scale, unbi-
ased genome-wide scan of CNVs in common pediatric664 The American Journal of Human Genetics 87, 661–666, Novembobesity. The loci uncovered in this present study are exclu-
sively observed in childhood obesity and replicated in
an independent case control data set from a different
ethnicity. The results are given extra credibility because
the well-established FTO10–14 locus is very strongly associ-
ated with both BMI and obesity in our EA cohort.11,30 We
did not observe association with any CNVs previously
reported in subjects with severe pediatric obesity and coex-
isting developmental delay.18 In addition, we did not have
probe coverage of the previously reported common CNV
flanking NEGR1 (MIM 613173) or encompassing SH2B1
(MIM 608937).17
Because these variants are individually rare, we would
postulate that they do not contribute greatly to the overall
‘‘missing heritability’’ in obesity, but they do present us
with potential insights in to the underlying biology of
childhood obesity; however, to the individuals harboring
these variants, they are very relevant to their disorder.
With new advances in sequencing, one would expect addi-
tional CNVs to be characterized in this condition, so theyer 12, 2010
Figure 2. Visualization of Representative Loci Most Frequently
Harboring Duplications
Duplications identified at the KIF2B and ARL15 loci. Vertical blue
lines indicate the SNP probe coverage. Green rectangles delineate
regions of copy number variation in individual cases for duplica-
tions. RefSeq gene boundaries are shown with vertical lines delin-
eating exons. Database of Genomic Variants entries from other
studies on avariety of platforms are shownas an additional control.
Figure 1. Visualization of Representative Loci Most Frequently
Harboring Deletions
Deletions identified at the EDIL3, S1PR5 and FOXP2 loci. Vertical
blue lines indicate the SNPprobe coverage. Red rectanglesdelineate
regions of copy number variation in individual cases for deletions.
RefSeq gene boundaries are shown with vertical lines delineating
exons. Database of Genomic Variants entries from other studies
on a variety of platforms are shown as an additional control.could collectively build up to ameaningful contribution to
the missing heritably for this trait.
Taken together, the results of our unbiased approach
to assessing the entire genome have revealed genes over-
lapping with CNVs that are exclusive to cases in two
different ethnicities and, to our knowledge, have not previ-
ously been directly implicated in the context of obesity.
Additional functional studies will be needed to fully char-
acterize the function of the genes at these loci in relation to
childhood obesity
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